Birgit Engesæter

1.4k total citations
41 papers, 1.1k citations indexed

About

Birgit Engesæter is a scholar working on Molecular Biology, Epidemiology and Genetics. According to data from OpenAlex, Birgit Engesæter has authored 41 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 12 papers in Epidemiology and 12 papers in Genetics. Recurrent topics in Birgit Engesæter's work include RNA Interference and Gene Delivery (13 papers), Virus-based gene therapy research (12 papers) and Cervical Cancer and HPV Research (11 papers). Birgit Engesæter is often cited by papers focused on RNA Interference and Gene Delivery (13 papers), Virus-based gene therapy research (12 papers) and Cervical Cancer and HPV Research (11 papers). Birgit Engesæter collaborates with scholars based in Norway, United States and Finland. Birgit Engesæter's co-authors include Lina Prasmickaite, Kristian Berg, Anders Høgset, Gunhild M. Mælandsmo, Pål Kristian Selbo, Anette Bonsted, Anette Weyergang, Marit Hellum, Øystein Fodstad and Even Angell‐Petersen and has published in prestigious journals such as PLoS ONE, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Birgit Engesæter

39 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Birgit Engesæter Norway 18 584 351 324 231 179 41 1.1k
Freddy E. Escorcia United States 21 825 1.4× 208 0.6× 259 0.8× 325 1.4× 178 1.0× 63 1.8k
Mark Castanares United States 17 1.0k 1.7× 428 1.2× 256 0.8× 291 1.3× 66 0.4× 31 1.7k
Anne C.E. Moor Netherlands 17 291 0.5× 668 1.9× 476 1.5× 147 0.6× 153 0.9× 29 1.2k
Lígia C. Gomes‐da‐Silva Portugal 21 637 1.1× 580 1.7× 777 2.4× 203 0.9× 288 1.6× 40 1.6k
Tracie Delgado United States 8 660 1.1× 77 0.2× 235 0.7× 278 1.2× 90 0.5× 11 1.5k
Hai Hu China 18 666 1.1× 190 0.5× 154 0.5× 551 2.4× 71 0.4× 33 1.3k
Anette Weyergang Norway 23 664 1.1× 841 2.4× 863 2.7× 195 0.8× 351 2.0× 43 1.7k
Anna Moshnikova United States 22 996 1.7× 139 0.4× 421 1.3× 184 0.8× 128 0.7× 45 1.7k
Shabnum Patel United States 14 455 0.8× 71 0.2× 227 0.7× 273 1.2× 74 0.4× 27 1.1k
Hasmik Agadjanian United States 14 351 0.6× 191 0.5× 113 0.3× 196 0.8× 278 1.6× 22 776

Countries citing papers authored by Birgit Engesæter

Since Specialization
Citations

This map shows the geographic impact of Birgit Engesæter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Engesæter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Engesæter more than expected).

Fields of papers citing papers by Birgit Engesæter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgit Engesæter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Engesæter. The network helps show where Birgit Engesæter may publish in the future.

Co-authorship network of co-authors of Birgit Engesæter

This figure shows the co-authorship network connecting the top 25 collaborators of Birgit Engesæter. A scholar is included among the top collaborators of Birgit Engesæter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgit Engesæter. Birgit Engesæter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bjørge, Tone, et al.. (2025). Cervical intraepithelial neoplasia grade 1 and long-term risk of progression and treatment. PLoS ONE. 20(4). e0320739–e0320739. 1 indexed citations
2.
Portnoy, Allison, Kine Pedersen, Stephen Sy, et al.. (2023). Cost‐effectiveness of primary human papillomavirus triage approaches among vaccinated women in Norway: A model‐based analysis. International Journal of Cancer. 154(6). 1073–1081. 2 indexed citations
3.
Nygård, Mari, Birgit Engesæter, Philip E. Castle, et al.. (2022). Randomized Implementation of a Primary Human Papillomavirus Testing–based Cervical Cancer Screening Protocol for Women 34 to 69 Years in Norway. Cancer Epidemiology Biomarkers & Prevention. 31(9). 1812–1822. 15 indexed citations
4.
Hashim, Dana, Birgit Engesæter, Gry Baadstrand Skare, et al.. (2020). Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening. British Journal of Cancer. 122(11). 1715–1723. 48 indexed citations
5.
Prasmickaite, Lina, Birgit Engesæter, Anette Weyergang, et al.. (2018). Enhanced targeting of triple-negative breast carcinoma and malignant melanoma by photochemical internalization of CSPG4-targeting immunotoxins. Photochemical & Photobiological Sciences. 17(5). 539–551. 22 indexed citations
6.
Lönnberg, Stefan, et al.. (2016). Impact of scheduled appointments on cervical screening participation in Norway: a randomised intervention. BMJ Open. 6(11). e013728–e013728. 13 indexed citations
7.
Fleten, Karianne G., Viví Ann Flørenes, Lina Prasmickaite, et al.. (2016). hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanoma. Cell Death Discovery. 2(1). 16081–16081. 10 indexed citations
8.
Engesæter, Birgit, Olav Engebraaten, Viví Ann Flørenes, & Gunhild M. Mælandsmo. (2012). Dacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma. PLoS ONE. 7(9). e45492–e45492. 14 indexed citations
9.
Rosnes, Anne Katrine Ree, Susan Shahzidi, Hiep Phuc Dong, et al.. (2012). Synthetic retinoid CD437 induces apoptosis and acts synergistically with TRAIL receptor-2 agonist in malignant melanoma. Biochemical and Biophysical Research Communications. 420(3). 516–522.
10.
Prasmickaite, Lina, et al.. (2011). Light-Directed Delivery of Nucleic Acids. Methods in molecular biology. 764. 107–121. 2 indexed citations
11.
Engesæter, Birgit, et al.. (2011). Targeting inhibitor of apoptosis proteins in combination with dacarbazine or TRAIL in melanoma cells. Cancer Biology & Therapy. 12(1). 47–58. 19 indexed citations
12.
Prasmickaite, Lina, et al.. (2010). Aldehyde Dehydrogenase (ALDH) Activity Does Not Select for Cells with Enhanced Aggressive Properties in Malignant Melanoma. PLoS ONE. 5(5). e10731–e10731. 67 indexed citations
13.
Engesæter, Birgit, et al.. (2007). Combined treatment with Ad‐hTRAIL and DTIC or SAHA is associated with increased mitochondrial‐mediated apoptosis in human melanoma cell lines. The Journal of Gene Medicine. 9(6). 440–451. 46 indexed citations
14.
Berg, Kristian, Marco Folini, Lina Prasmickaite, et al.. (2007). Photochemical Internalization: A New Tool for Drug Delivery. Current Pharmaceutical Biotechnology. 8(6). 362–372. 110 indexed citations
15.
Engesæter, Birgit, et al.. (2006). Photochemically mediated delivery of AdhCMV-TRAIL augments the TRAIL-induced apoptosis in colorectal cancer cell lines. Cancer Biology & Therapy. 5(11). 1511–1520. 10 indexed citations
16.
Engesæter, Birgit, et al.. (2005). Transgene delivery and gelonin cytotoxicity enhanced by photochemical internalization in fibroblast-like synoviocytes (FLS) from rheumatoid arthritis patients. Photochemical & Photobiological Sciences. 4(4). 341–347. 12 indexed citations
17.
Hellum, Marit, Anders Høgset, Birgit Engesæter, et al.. (2003). Photochemically enhanced gene delivery with cationic lipid formulations. Photochemical & Photobiological Sciences. 2(4). 407–411. 19 indexed citations
18.
Høgset, Anders, Birgit Engesæter, Lina Prasmickaite, et al.. (2002). Light-induced adenovirus gene transfer, an efficient and specific gene delivery technology for cancer gene therapy. Cancer Gene Therapy. 9(4). 365–371. 65 indexed citations
19.
Prasmickaite, Lina, Anders Høgset, Pål Kristian Selbo, et al.. (2002). Photochemical disruption of endocytic vesicles before delivery of drugs: a new strategy for cancer therapy. British Journal of Cancer. 86(4). 652–657. 100 indexed citations
20.
Høgset, Anders, Lina Prasmickaite, Marit Hellum, et al.. (2002). Photochemical transfection: a technology for efficient light-directed gene delivery.. Somatic Cell and Molecular Genetics. 27(1/6). 97–113. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Freddy E. Escorcia Breakdown of academic impact, for papers by Mark Castanares Breakdown of academic impact, for papers by Anne C.E. Moor Breakdown of academic impact, for papers by Lígia C. Gomes‐da‐Silva Breakdown of academic impact, for papers by Tracie Delgado Breakdown of academic impact, for papers by Hai Hu Breakdown of academic impact, for papers by Anette Weyergang Breakdown of academic impact, for papers by Anna Moshnikova Breakdown of academic impact, for papers by Shabnum Patel Breakdown of academic impact, for papers by Hasmik Agadjanian
Rankless by CCL
2026